InvivoGen's product citations
InvivoGen’s products are frequently cited in peer-reviewed publications for a wide variety of applications and uses. Browse our product citations below.
Please note: By clicking on the product name, you can access via the ‘Citations’ tab all references of the product (click ‘load more’).
Citations search
You can search by ‘Product Name’ or ‘Year’.
| Product | Citation | Year | Journal | Authors | Page |
|---|---|---|---|---|---|
| LPS-EB (LPS from E. coli O111:B4) | TASL is the SLC15A4-associated adaptor for IRF5 activation by TLR7–9 | 2020 | Nature | Heinz L.X. et al. | DOI: 10.1038/s41586-020-2282-0 |
| THP1-Dual™ Cells | TASL is the SLC15A4-associated adaptor for IRF5 activation by TLR7–9 | 2020 | Nature | Heinz L.X. et al. | DOI: 10.1038/s41586-020-2282-0 |
| R848 (Resiquimod) | TASL is the SLC15A4-associated adaptor for IRF5 activation by TLR7–9 | 2020 | Nature | Heinz L.X. et al. | DOI: 10.1038/s41586-020-2282-0 |
| ssRNA41/LyoVec™ | TASL is the SLC15A4-associated adaptor for IRF5 activation by TLR7–9 | 2020 | Nature | Heinz L.X. et al. | DOI: 10.1038/s41586-020-2282-0 |
| CL075 (3M002) | TASL is the SLC15A4-associated adaptor for IRF5 activation by TLR7–9 | 2020 | Nature | Heinz L.X. et al. | DOI: 10.1038/s41586-020-2282-0 |
| ODN 2006 (ODN 7909) | TASL is the SLC15A4-associated adaptor for IRF5 activation by TLR7–9 | 2020 | Nature | Heinz L.X. et al. | DOI: 10.1038/s41586-020-2282-0 |
| MDP | TASL is the SLC15A4-associated adaptor for IRF5 activation by TLR7–9 | 2020 | Nature | Heinz L.X. et al. | DOI: 10.1038/s41586-020-2282-0 |
| FLA-ST (Standard or Ultrapure) | TASL is the SLC15A4-associated adaptor for IRF5 activation by TLR7–9 | 2020 | Nature | Heinz L.X. et al. | DOI: 10.1038/s41586-020-2282-0 |
| Pam3CSK4 | TASL is the SLC15A4-associated adaptor for IRF5 activation by TLR7–9 | 2020 | Nature | Heinz L.X. et al. | DOI: 10.1038/s41586-020-2282-0 |
| C12-iE-DAP | TASL is the SLC15A4-associated adaptor for IRF5 activation by TLR7–9 | 2020 | Nature | Heinz L.X. et al. | DOI: 10.1038/s41586-020-2282-0 |
| BX795 | TASL is the SLC15A4-associated adaptor for IRF5 activation by TLR7–9 | 2020 | Nature | Heinz L.X. et al. | DOI: 10.1038/s41586-020-2282-0 |
| Human IL-1α & IL-1β Reporter HEK 293 Cells | A Translocation Pathway for Vesicle-Mediated Unconventional Protein Secretion. | 2020 | Cell | Zhang M. et al. | DOI: 10.1016/j.cell.2020.03.031 |
| Mouse TLR5 Reporter HEK293 Cells (NF-κB) | Oral vaccination with live attenuated Yersinia pseudotuberculosis strains del... | 2020 | Vaccine. | Singh A.K. et al. | DOI: 10.1016/j.vaccine.2020.03.055 |
| DNA synthesis inhibitor | Poly(ethylene glycol)–Poly(beta-amino ester)-Based Nanoparticles for Suicide ... | 2020 | CS Biomater. Sci. Eng. | Kim J. et al. | DOI: 10.1021/acsbiomaterials.0c00116 |
| Human TLR7 Reporter HEK293 Cells (NF-κB) | Identification and validation of a novel dual small-molecule TLR2/8 antagonist. | 2020 | Biochem Pharmacol. | Grabowski M. et al. | DOI: 10.1016/j.bcp.2020.113957 |
| Human TLR2 Reporter HEK293 Cells (NF-κB) | Identification and validation of a novel dual small-molecule TLR2/8 antagonist. | 2020 | Biochem Pharmacol. | Grabowski M. et al. | DOI: 10.1016/j.bcp.2020.113957 |
| Human TLR2 and TLR1 Reporter HEK293 Cells (NF-κB) | Identification and validation of a novel dual small-molecule TLR2/8 antagonist. | 2020 | Biochem Pharmacol. | Grabowski M. et al. | DOI: 10.1016/j.bcp.2020.113957 |
| Human TLR8 Reporter HEK293 Cells (NF-κB) | Identification and validation of a novel dual small-molecule TLR2/8 antagonist. | 2020 | Biochem Pharmacol. | Grabowski M. et al. | DOI: 10.1016/j.bcp.2020.113957 |
| Fc-hDectin-1a | Fluconazole and Lipopeptide Surfactin Interplay During Candida albicans Plasm... | 2020 | Pharmaceutics. | Suchodolski J. et al. | DOI: 10.3390/pharmaceutics12040314 |
| Poly(A:U) | Analysis of RNA Interference (RNAi) Biopesticides: Double-Stranded RNA (dsRNA... | 2020 | Environ Sci Technol. | Zhang K. et al. | DOI: 10.1021/acs.est.9b07781 |